Did pepgen inc. mislead investors? shareholder rights advocates at levi & korsinsky investigate- pepg

New york, ny / accesswire / august 5, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of pepgen inc. ("pepgen") (nasdaq:pepg) concerning possible violations of federal securities laws. on july 30, 2024, pepgen released data from its ongoing phase 2 trial of its drug candidate pgn-edo51.
PEPG Ratings Summary
PEPG Quant Ranking